Community Research and Development Information Service - CORDIS

Results 1 - 10 of 92
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > 
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria
ID: 279277
Start date: 2012-01-01, End date: 2018-12-31
Patients with diabetes are at risk of developing diabetic nephropathy, which will ultimately result in the requirement for renal replacement therapy and is also associated with high cardiovascular morbidity and mortality. Detection of low concentrations of albuminuria in urin...
Programme: FP7-HEALTH
Record Number: 101813
Last updated on: 2018-01-22
Target binders
[PROJECT] TARGETBINDER - Target binders
ID: 278403
Start date: 2012-01-01, End date: 2014-12-31
We want to further develop our tools and technologies for high-throughput research, with the final goals being (I.) the particle-based combinatorial synthesis of 1 Mio different peptides on a glass slide for chemical costs of ~50€ (KIT, CBL, MS, TUV), and (II.) the labelling-...
Programme: FP7-HEALTH
Record Number: 101793
Last updated on: 2018-01-03
Next Generation Genome Based High Resolution Tracing of Pathogens
ID: 278864
Start date: 2012-01-01, End date: 2016-06-30
"Next generation sequencing (NGS) has fundamentally altered genomic research. New developments will bring NGS costs and performance down to an everybody's technology with extreme potential for ultra fast and accurate molecular typing and diagnostic as it provides the ultimate...
Programme: FP7-HEALTH
Record Number: 101800
Last updated on: 2017-12-18
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis
ID: 279174
Start date: 2012-01-01, End date: 2014-12-31
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide with little variation of the prevalence among countries. The current pharmacological manage...
Programme: FP7-HEALTH
Record Number: 102108
Last updated on: 2017-12-11
New Technologies and Production Tools for Complex Protein Biologics
ID: 279039
Start date: 2011-11-01, End date: 2015-10-31
ComplexINC conceptualizes and systematically generates advanced tool-kits to enable high-throughput assembly of complex biologics and metabolic pathways in eukaryotic expression systems, for micro- to large scale production of high-quality protein specimens for drug discovery...
Programme: FP7-HEALTH
Record Number: 102213
Last updated on: 2017-12-11
A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects
ID: 279024
Start date: 2011-10-01, End date: 2016-09-30
Large full-thickness skin defects resulting from burns, soft tissue trauma, congenital giant nevi, tumour resection, and disease leading to skin necrosis, represent a significant and common clinical problem worldwide. This problem is far from being solved. The main challenge ...
Programme: FP7-HEALTH
Record Number: 101996
Last updated on: 2017-12-11
High-throughput peptidomics and transcriptomics of animal venoms for discovery of novel therapeutic peptides and innovative drug development
ID: 278346
Start date: 2011-11-01, End date: 2015-10-31
Animal venoms are complex cocktails of peptides that have enormous potential as novel therapeutic leads. Replicating in vitro the diversity of venoms by generating large synthetic combinatorial peptide libraries will solve the challenge of working with limited amounts of natu...
Programme: FP7-HEALTH
Record Number: 101790
Last updated on: 2017-12-11
Identification, homing and monitoring of therapeutic cells for regenerative medicine – Identify, Enrich, Accelerate
ID: 279288
Start date: 2012-03-01, End date: 2017-02-28
Regenerative medicine focuses on repairing or replacing tissue or organ function lost due to damage or congenital defects using appropriate cells for therapy that have healing capacities like stem cells or progenitor cells. Although regenerative medicine has the potential for...
Programme: FP7-HEALTH
Record Number: 102498
Last updated on: 2017-12-07
The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality  in acute myocardial infarction
ID: 278967
Start date: 2011-11-01, End date: 2017-10-31
Although the long term prognosis of patients suffering acute myocardial infarction (AMI) has improved since the introduction of reperfusion therapies and primary angioplasty, the 1 year mortality of patients with AMI and resultant left ventricular systolic dysfunction (LVSD) ...
Programme: FP7-HEALTH
Record Number: 101806
Last updated on: 2017-12-07
Biofilm Alliance
[PROJECT] BALI - Biofilm Alliance
ID: 278890
Start date: 2011-10-01, End date: 2016-09-30
Infections by biofilm-forming microorganisms on indwelling medical devices such as catheters, prosthetic joints and internal fracture fixation devices pose a serious health threat. Overall, approximately 3% of all patients receiving such devices develop biofilm infections, wi...
Programme: FP7-HEALTH
Record Number: 102212
Last updated on: 2017-12-07
12 3 4 5 6 7 8 9 10 > 
List retrieved on: 2018-10-23
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top